AU Patent

AU2007323644A1 — Compounds modulating c-fms and/or c-kit activity and uses therefor

Assigned to Daiichi Sankyo Inc · Expires 2008-05-29 · 18y expired

What this patent protects

Patent listed against pexidartinib-hydrochloride.

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: AU2007323644A1
Jurisdiction: AU
Classification: —
Expires: 2008-05-29
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.